Gateway Advisory’s Medtronic MDT Stock Holding History

Gateway Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,067	Closed	-$248K	–	88
2017 Q4	$248K	Sell	3,067 -128	-4%	-$10.3K	0.07%	82
2017 Q3	$248K	Sell	3,195 -15	-0.5%	-$1.25K	0.07%	65
2017 Q2	$285K	Buy	3,210 +292	+10%	+$24.6K	0.09%	69
2017 Q1	$234K	Buy	+2,918	New	+$228K	0.07%	71
2016 Q3	–	Sell	-2,270	Closed	-$201K	–	54
2016 Q2	$201K	Buy	+2,270	New	+$184K	0.08%	42

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Gateway Advisory's MDT Position: Q1 2018 in Review

Gateway Advisory sold out of Medtronic (MDT) in Q1 2018, closing a stake of 3,067 shares — an estimated $248K sold.

Gateway Advisory first reported a position in MDT in Q2 2016 and held it in 5 quarters. The position peaked at $285K in Q2 2017. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

Gateway Advisory reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
Gateway Advisory sold 3,067 Medtronic shares in Q1 2018, an estimated $248K.
Gateway Advisory first reported a position in Medtronic in Q2 2016 and held it in 5 quarters.
Gateway Advisory's Medtronic position peaked at $285K in Q2 2017.
1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Gateway Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.